TrialMedicina (Kaunas, Lithuania)2025

Effect of Remimazolam and Propofol on Blood Glucose and Serum Inflammatory Markers in Patients with Type 2 Diabetes: A Clinical Trial with Prospective Randomized Control.

Sang Hun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.